ASPRONI, Battistina
 Distribuzione geografica
Continente #
NA - Nord America 1.531
EU - Europa 816
AS - Asia 599
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 1
Totale 2.958
Nazione #
US - Stati Uniti d'America 1.525
CN - Cina 415
UA - Ucraina 360
IT - Italia 131
DE - Germania 127
SG - Singapore 100
FI - Finlandia 57
SE - Svezia 56
TR - Turchia 52
GB - Regno Unito 28
BE - Belgio 15
CZ - Repubblica Ceca 11
FR - Francia 10
KR - Corea 10
IR - Iran 7
CA - Canada 6
AU - Australia 5
EU - Europa 5
IN - India 5
RO - Romania 4
BG - Bulgaria 3
NL - Olanda 3
BD - Bangladesh 2
DK - Danimarca 2
HU - Ungheria 2
IQ - Iraq 2
JP - Giappone 2
SA - Arabia Saudita 2
AL - Albania 1
BR - Brasile 1
ID - Indonesia 1
IE - Irlanda 1
MC - Monaco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
Totale 2.958
Città #
Chandler 430
Jacksonville 227
Nanjing 126
Princeton 126
New York 76
Dearborn 69
Singapore 61
Sassari 57
Ann Arbor 56
Izmir 50
Wilmington 47
Shenyang 42
Beijing 32
Nanchang 28
Jiaxing 27
Woodbridge 25
Tianjin 24
Changsha 20
Boardman 18
Ningbo 17
Hebei 16
Brussels 15
Jinan 15
Santa Clara 15
Ashburn 14
Norwalk 13
Zhengzhou 12
Brno 11
Hangzhou 11
Seoul 10
Andover 9
Kunming 9
Taizhou 9
Leawood 8
Auburn Hills 7
Guangzhou 7
Helsinki 7
Mountain View 7
San Mateo 7
Quartu Sant'Elena 6
Dallas 5
Monmouth Junction 5
Munich 5
San Francisco 5
Toronto 5
Albissola Marina 4
Ardabil 4
Los Angeles 4
Hanover 3
Hefei 3
Lanzhou 3
Rome 3
Sofia 3
Augusta 2
Baghdad 2
Budapest 2
Cagliari 2
Castel Gandolfo 2
Haikou 2
Huskvarna 2
Incisa 2
Milan 2
Modena 2
Quartucciu 2
Riyadh 2
Seattle 2
Sydney 2
Tokyo 2
Alexandria 1
Bangalore 1
Bangkok 1
Belgrade 1
Brierley Hill 1
Canberra 1
Changchun 1
Chengdu 1
Chicago 1
Chisinau 1
Cleveland 1
Dublin 1
Edinburgh 1
Empoli 1
Florence 1
Ft. Washington 1
Hunedoara 1
Lappeenranta 1
Laurel 1
Lisbon 1
Logan 1
Melbourne 1
Miami 1
Monaco 1
Montreal 1
Mumbai 1
Orange 1
Osimo 1
Paris 1
Perugia 1
Qingdao 1
Quzhou 1
Totale 1.880
Nome #
Isolation, Characterization and Pharmacological Activity of Magydaris Pastinaca (LAM) Paol. Glucosides 83
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 81
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 80
Determination of Amphetamines in human whole blood by capillary electrophoresis with photodiode array detection 79
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 65
Attività sul SNC di cicloesilamidi variamente sostituite 64
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 63
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 62
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 62
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 62
Attività farmacologica delle Carboline: sintesi di nuove strutture 61
Fungicidal Activity of Some o-nitrophenyl-hydrazones 60
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 60
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 58
Attività sul SNC di cicloesilamidi variamente sostituite - XI° Convegno Nazionale della Divisione di Chimica Farmaceutica della Società Chimica Italiana. Bari 2-5 Ottobre 1994, P95 (pag. 120) 57
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 56
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 55
Synthesis of N-[4-(Alkyl)cyclohexyl]-substituted benzamides with anti-inflammatory and analgesic activities 51
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 50
Determination of Amphetamines in Human Whole Blood by CE with DAD Detection 49
Synthesis of N-[4-propyl)cyclohexyl]-amides with Anti-Inflammatory and Analgesic Activities 49
Sensitization to Methyl methacrylate in the Plastic Catheter of an Insulin Pump Infusion Set 48
Attività Farmacologica delle g-carboline: sintesi di nuove strutture- XI° Convegno Nazionale della Divisione di Chimica Farmaceutica della Società Chimica Italiana. Bari 2-5 Ottobre 1994, P94 (pag. 119) 48
Synthesis and biological evaluation of novel CB2 ligands 48
Synthesis of substituted N1-4-piperidyl-N1-3-pyridyl-amides with antiarrythmic activity Note 1 47
Determination amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection 47
Synthesis of biologically active bridged diazabicycloheptanes 47
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 47
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 47
Synthesis of N -[ 4 (– propyl) cyclohexyl] - amides with anti – inflammatory and anlgesic activities 47
Synthesis and binding affinity of N-6 biaryl-N-propionyl-3,6-diazabicyclo[3.1.1]heptanes. 47
Biotrasformazione degli xenobiotici. In: Chimica Tossicologica 46
Synthesis and SAR study of 2-substituted imidazo[2,1-b][1,3]benzothiazoles and related compounds endowed with affinity for dopamine D2 receptors as potential antipsychotics 45
Synthesis and structure-activity relationships at GABAA receptor in rat brain and differential electrophysiological profile at recombinant human GABAA receptor of a series of substituted 1,2-diphenyl-imidazoles 45
Ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-4-imidazolecarboxylate is a Novel Positive Modulator of GABAA Receptors 45
Anti-inflammatory and Analgesic Amides: New Developments 45
Synthesis, Structure-Activity Relationships at the GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at the Recombinant Human GABAA Receptor of a Series of Substituted 1,2-Diphenylimidazoles 44
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 44
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 43
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 43
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 43
Isolation, characterization and pharmacological activity of Magydaris pastinacea Lam. Paol. glucosides 43
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 42
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 42
Synthesis and Pharmacological Evaluation of 1-[(1,2-Diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with Clozapine-Like Mixed Activities at Dopamine D2, Serotonin and GABAA Receptors 41
Nuovi Derivati 1,2-difenil-imidazolici come potenti ed efficaci modulatori allosterici positivi del recettore GABAA. Sardinia Chem 2004. Giornata di studio dedicata alla chimica organica delle molecole biologicamente attive. P32 (pag. 95) 40
Synthesis of Substituted N1-4-piperidyl-N1-3-pyridyl-amides with Antiarrythmic Activity 40
Fungicidal activity of some o-nitrophenil-hidrazones 40
Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivatives 39
Synthesis and Pharmacological Evaluation of 1,2-Diphenyl-4-(aminomethyl)imidazoles with Clozapine-Like Mixed Activities at Dopamine D2, Serotonin, and GABAA Receptors. XXI° Congresso Nazionale della Società Chimica Italiana, Torino, 22-27 Giugno 2003, FA-CO-001 (Atti, Vol.1; Conferenze Plenarie-Comunicazioni Orali) 38
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 36
Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors 34
Nuovi derivati 1,2-difenil-imidazolici come potenti ed efficaci modulatori allosterici positivi del recettore GABAA 32
A survey of Recent Patents on CB2 Agonists in the Management of Pain 32
Synthesis and biological evaluation of novel delta (δ) opioid receptor ligands with diazatricyclodecane skeletons 30
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 30
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors 30
Isolation, characterization and pharmacological activity ofMagydaris pastinacea(Lam.) Paol.glucosides 28
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors 28
Fungicidal activity of some o-nitrophenyl-hydrazones 27
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 27
Tricyclic pyrazoles. Part 5. novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 ligands using molecular hybridization based on scaffold hopping 26
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 26
Synthesis and sar study of 2-substituted imidazo[2,1-b] [1,3]benzothiazoles and related compounds endowed with affinity for dopamine D2receptors as potential antipsychotics 22
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction 16
Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction 9
Totale 3.021
Categoria #
all - tutte 15.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020461 0 0 54 4 57 65 114 6 72 20 66 3
2020/2021473 60 2 70 5 60 11 61 17 66 69 46 6
2021/2022321 37 2 0 3 3 0 19 27 20 23 48 139
2022/2023772 67 55 12 145 69 128 0 110 133 7 31 15
2023/2024252 36 16 9 9 30 64 0 17 0 3 42 26
2024/2025104 9 11 84 0 0 0 0 0 0 0 0 0
Totale 3.021